Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand

被引:0
作者
Vanessa Valdes
Michael A. Nardi
Lindsay Elbaum
Jeffrey S. Berger
机构
[1] New York University School of Medicine,Division of Cardiology, Department of Medicine
[2] New York University School of Medicine,Department of Pediatrics and Pathology
[3] New York University School of Medicine,Department of Medicine, Division of Hematology
来源
Journal of Thrombosis and Thrombolysis | 2015年 / 40卷
关键词
Platelets; CD40-Ligand; P-Selectin; Biomarker; Aspirin;
D O I
暂无
中图分类号
学科分类号
摘要
Platelet markers [soluble CD40 ligand (sCD40L) and soluble p selectin (sPselectin)] are associated with platelet activation and cardiovascular events. We sought to investigate the reproducibility of these markers over time and the effect of low-dose aspirin on sCD40L and sPselectin in plasma and serum. Following an overnight fast, 40 healthy volunteers had weekly phlebotomy and were administered aspirin 81 mg/day between weeks 3 and 4. Reproducibility over time was assessed by coefficient of variation (CV) and inter-class correlation coefficient. Correlation between markers was assessed using Pearson r statistic. Difference between levels pre- and post-aspirin was measured with Wilcoxon signed-rank test. Data are presented as median (interquartile range). sCD40L and sPselectin measurements were reproducible over time in plasma and serum (CV < 10 %). Measurement of sCD40L and sPselectin in plasma correlated with levels in serum before aspirin and after aspirin. There was no significant correlation between sCD40L and sPselectin. After 1-week of aspirin 81 mg/day, there was a reduction in sCD40L and sPselectin in serum and plasma, respectively. Soluble CD40L and sPselectin are independent markers that are reproducible over time in both plasma and sera and are reduced by 1-week of low-dose aspirin.
引用
收藏
页码:83 / 87
页数:4
相关论文
共 64 条
  • [1] Blann AD(1997)Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 128 135-138
  • [2] Lip GY(2011)Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the data J Thromb Thrombolysis 32 201-208
  • [3] Sharma G(2009)The CD40/CD40 ligand system: linking inflammation with atherothrombosis J Am Coll Cardiol 54 669-677
  • [4] Berger JS(2003)Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2661-2666
  • [5] Antoniades C(2003)CD40-CD40L and platelet function: beyond hemostasis Circ Res 92 944-946
  • [6] Bakogiannis C(2001)Soluble P-selectin and the risk of future cardiovascular events Circulation 103 491-495
  • [7] Tousoulis D(2001)Soluble CD40L and cardiovascular risk in women Circulation 104 2266-2268
  • [8] Antonopoulos AS(2014)Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy Platelets 25 188-192
  • [9] Stefanadis C(2010)Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis J Thromb Haemost 8 148-156
  • [10] Burger PC(2004)Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma J Thromb Haemost 2 2067-2069